Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pall buys Gelman in stock swap:

This article was originally published in Clinica

Executive Summary

Pall will acquire the manufacturer of microfiltration products, Gelman Sciences, for $33 a share in a stock swap. The deal is subject to the approval of Gelman shareholders. Gelman had previously signed an agreement to merge with another company, Memtec. This transaction was terminated by Gelman's board when it concluded that the Pall deal was more favourable to Gelman's shareholders.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel